R.H. Bluestein & Co’s Exelon EXC Stock Holding History

R.H. Bluestein & Co’s Portfolio EXC Stock Details EXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-9,814	Closed	-$255K	–	303
2016 Q2	$255K	Buy	+9,814	New	+$243K	0.02%	217

Other funds holding EXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

R.H. Bluestein & Co's EXC Position: Q3 2016 in Review

R.H. Bluestein & Co sold out of Exelon (EXC) in Q3 2016, closing a stake of 9,814 shares — an estimated $255K sold.

R.H. Bluestein & Co first reported a position in EXC in Q2 2016 and held it in 1 quarter. The position peaked at $255K in Q2 2016. 749 funds tracked by Wall St. Rank hold EXC as of Q3 2016.

R.H. Bluestein & Co reported no remaining Exelon position as of Q3 2016 after selling out during the quarter.
R.H. Bluestein & Co sold 9,814 Exelon shares in Q3 2016, an estimated $255K.
R.H. Bluestein & Co first reported a position in Exelon in Q2 2016 and held it in 1 quarter.
R.H. Bluestein & Co's Exelon position peaked at $255K in Q2 2016.
749 funds tracked by Wall St. Rank held Exelon as of Q3 2016.

Based on R.H. Bluestein & Co's 13F filing for Q3 2016, filed 14 Nov 2016.